Anti-CD20 therapy for older patients with B-cell non-Hodgkin lymphoma in the context of epidemic normalization-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Anti-CD20 therapy for older patients with B-cell non-Hodgkin lymphoma in the context of epidemic normalization

Published:2024-07 Issue:7 Volume:47 Page:3290-3292
ISSN:1015-9584
Container-title:Asian Journal of Surgery
language:en
Short-container-title:Asian Journal of Surgery

Author:

Zhang Dongdong^ORCID,Xu Shuangnian

Publisher

Elsevier BV

Reference5 articles.

1. Impact of COVID-19 on case fatality rate of patients with cancer during the Omicron wave;Lee;Cancer Cell,2022

2. Long-term use of immunosuppressive medicines and in-hospital COVID-19 outcomes: a retrospective cohort study using data from the National COVID Cohort Collaborative;Andersen;The Lancet.Rheumatol,2022

3. Evolutionary analysis of Omicron variant BF.7 and BA.5.2 pandemic in China;Sun;J. Biosaf. Biosecur.,2023

4. Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study;Passamonti;Lancet.Haematol,2020

5. Association of immunoglobulin levels, infectious risk, and mortality with rituximab and hypogammaglobulinemia;Barmettler;JAMA Netw Open,2018

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3